J. Cadranel
- Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancerBy J. Cadranel, G. Zalcman and L. SequistJ. CadranelG. Zalcman
- Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patientsBy C. Mayaud, A. Parrot and J. CadranelC. MayaudA. Parrot
- Primary pulmonary lymphomaBy J. Cadranel, M. Wislez and M. AntoineJ. CadranelM. Wislez
- Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositisBy V. Cottin, F. Thivolet-Béjui, M. Reynaud-Gaubert, J. Cadranel, P. Delaval, P-J. Ternamian, J-F. Cordier and and the Groupe d'Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P)V. CottinF. Thivolet-BéjuiM. Reynaud-GaubertJ. CadranelP. DelavalP-J. Ternamian
- Clinical characteristics and prognostic factors of pulmonary MALT lymphomaBy R. Borie, M. Wislez, G. Thabut, M. Antoine, A. Rabbat, L-J. Couderc, I. Monnet, H. Nunes, F-X. Blanc, H. Mal, A. Bergeron, D. Dusser, D. Israël-Biet, B. Crestani and J. CadranelR. BorieM. WislezG. ThabutM. AntoineA. RabbatL-J. CoudercI. MonnetH. NunesF-X. BlancH. MalA. BergeronD. DusserD. Israël-BietB. Crestani
- Rituximab-induced lung disease: a systematic literature reviewBy H. Lioté, F. Lioté, B. Séroussi, C. Mayaud and J. CadranelH. LiotéF. LiotéB. SéroussiC. Mayaud
- Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortalityBy N. de Prost, A. Parrot, C. Picard, P-Y. Ancel, C. Mayaud, M. Fartoukh and J. CadranelN. de ProstA. ParrotC. PicardP-Y. AncelC. MayaudM. Fartoukh
- Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3By I. Borget, J. Cadranel, J-P. Pignon, E. Quoix, B. Coudert, V. Westeel, E. Dansin, J. Madelaine, A. Madroszyk, S. Friard, C. Daniel, F. Morin, C. Chouaid and the ERMETIC Collaborative GroupI. BorgetJ. CadranelJ-P. PignonE. QuoixB. CoudertV. WesteelE. DansinJ. MadelaineA. MadroszykS. FriardC. DanielF. Morin
- Surrogate markers predicting overall survival for lung cancer: ELCWP recommendationsBy T. Berghmans, F. Pasleau, M. Paesmans, Y. Bonduelle, J. Cadranel, I. Cs Toth, C. Garcia, V. Giner, S. Holbrechts, J.J. Lafitte, J. Lecomte, I. Louviaux, E. Markiewicz, A.P. Meert, M. Richez, M. Roelandts, A. Scherpereel, Ch. Tulippe, P. Van Houtte, P. Van Schil, C. Wachters, V. Westeel and J.P. SculierT. BerghmansF. PasleauM. PaesmansY. BonduelleJ. CadranelI. Cs TothC. GarciaV. GinerS. HolbrechtsJ.J. LafitteJ. LecomteI. LouviauxE. MarkiewiczA.P. MeertM. RichezM. RoelandtsA. ScherpereelCh. TulippeP. Van HoutteP. Van SchilC. WachtersV. Westeel
- Comparative cost-effectiveness of three strategies for guiding second-line erlotinib initiation in non small-cell lung cancer: a French prospective multicenter study (ERMETIC Project Part 3)By I. Borget, J. Cadranel, J-P. Pignon, E. Quoix, B. Coudert, V. Westeel, E. Dansin, J. Madelaine, A. Madroszyk, S. Friard, C. Daniel, F. Morin, C. Chouaid and the ERMETIC Collaborative GroupArticle | Published in 2011 in European Respiratory JournalI. BorgetJ. CadranelJ-P. PignonE. QuoixB. CoudertV. WesteelE. DansinJ. MadelaineA. MadroszykS. FriardC. DanielF. Morin
- Surrogate markers predicting overall survival for lung cancer: elcwp recommendationsBy T. Berghmans, F. Pasleau, M. Paesmans, Y. Bonduelle, J. Cadranel, I. Cs Toth, C. Garcia, V. Giner, S. Holbrechts, J.J. Lafitte, J. Lecomte, I. Louviaux, E. Markiewicz, A.P. Meert, M. Richez, M. Roelandts, A. Scherpereel, Ch. Tulippe, P. Van Houtte, P. Van Schil, C. Wachters, V. Westeel and J.P. SculierArticle | Published in 2011 in European Respiratory JournalT. BerghmansF. PasleauM. PaesmansY. BonduelleJ. CadranelI. Cs TothC. GarciaV. GinerS. HolbrechtsJ.J. LafitteJ. LecomteI. LouviauxE. MarkiewiczA.P. MeertM. RichezM. RoelandtsA. ScherpereelCh. TulippeP. Van HoutteP. Van SchilC. WachtersV. Westeel
- Clinical characteristics and prognostic factors of pulmonary MALT lymphomaBy R. Borie, M. Wislez, G. Thabut, M. Antoine, A. Rabbat, L-J. Couderc, I. Monnet, H. Nunes, F-X. Blanc, H. Mal, A. Bergeron, D. Dusser, D. Israël-Biet, B. Crestani and J. CadranelArticle | Published in 2009 in European Respiratory JournalR. BorieM. WislezG. ThabutM. AntoineA. RabbatL-J. CoudercI. MonnetH. NunesF-X. BlancH. MalA. BergeronD. DusserD. Israël-BietB. Crestani
- Diffuse alveolar hemorrhage: factors associated with in-hospital and long-term mortalityBy N. de Prost, A. Parrot, C. Picard, P-Y. Ancel, C. Mayaud, M. Fartoukh and J. CadranelArticle | Published in 2009 in European Respiratory JournalN. de ProstA. ParrotC. PicardP-Y. AncelC. MayaudM. Fartoukh
- Rituximab-induced lung disease: a systematic literature reviewBy H. Lioté, F. Lioté, B. Séroussi, C. Mayaud and J. CadranelArticle | Published in 2009 in European Respiratory JournalH. LiotéF. LiotéB. SéroussiC. Mayaud
- Genetic profiling and EGFR-directed therapy in NSCLC: evidence and clinical implicationsBy J. Cadranel, G. Zalcman and L. SequistArticle | Published in 2010 in European Respiratory JournalJ. CadranelG. Zalcman
- Genetic profiling and EGFR-directed therapy in NSCLC: evidence and clinical implicationsBy J. Cadranel, G. Zalcman and L. SequistArticle | Published in 2010 in European Respiratory JournalJ. CadranelG. Zalcman
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
